ArticleAntibiotics (Basel, Switzerland)2026
In Vitro Restoration of Colistin Susceptibility by Ivacaftor Synergy with Limited Reproducibility in a Murine Pneumonia Model.
Ana Verónica Halperin, Franziska Schwartz, Lars Christophersen, José Pérez-Del Palacio, Manuel Ponce-Alonso, José Avendaño-Ortiz, Juan de Dios Caballero, Rafael Cantón, Claus Moser, Rosa Del Campo
Abstract read
In one paragraphArticle in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Ana Verónica HalperinServicio de Microbiologia, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-3652-7915 Franziska SchwartzDepartment of Clinical Microbiology, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Lars ChristophersenDepartment of Clinical Microbiology, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
José Pérez-Del PalacioFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, 18016 Granada, Spain.
Manuel Ponce-AlonsoServicio de Microbiologia, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0002-3239-9373 José Avendaño-OrtizServicio de Microbiologia, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-2774-1821 Juan de Dios CaballeroServicio de Microbiologia, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
Rafael CantónServicio de Microbiologia, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.ORCID 0000-0003-1675-3173 Claus MoserDepartment of Clinical Microbiology, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
Rosa Del CampoCIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-1147-7923 Funding
Instituto de Salud Carlos III CB21/13/0084Instituto de Salud Carlos III PI22/01045Instituto de Salud Carlos III PMP22/00092Instituto Ramón y Cajal de Investigación Sanitaria IMP23_C10 and IMP19_10Instituto Ramón y Cajal de Investigación Sanitaria ROOK-ESKAPIA ProjectNovo Nordisk Foundation NNF17OC0025074
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
colistin resistancein vivo synergyivacaftorKlebsiella pneumoniaephosphoethanolaminePseudomonas aeruginosa
Identifiers
PMID42041377
PMCPMC13113029
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390